Mirador Therapeutics
Mirador Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 3 tracked investors.
About Mirador Therapeutics
Mirador Therapeutics is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 3 investors associated with the company.
Mirador Therapeutics is a clinical-stage precision medicine company focused on developing first-in-class or best-in-class therapeutics for immune-mediated inflammatory and fibrotic diseases. It utilizes its proprietary Mirador360™ precision development engine, which leverages advances in human genetics, multi-modal data, and AI to accelerate the discovery and development of novel therapies.
Explore Mirador Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.